Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa

May 29, 2015 updated by: Connie Celum, University of Washington

An Evaluation of Strategies to Increase Testing and Linkages of HIV Positive Individuals to Care and HIV Negative Men to Male Circumcision in Sub-Saharan Africa

The purpose of this study is to determine efficient, scalable, evidence-based strategies to link HIV positive individuals to care and HIV negative individuals to prevention measures, such as voluntary male circumcision.

Study Overview

Detailed Description

New strategies for HIV testing and linkages to care are needed, since only a minority of African adults have been tested in many settings and a drop-off occurs at each step from HIV and CD4 testing, remaining in pre-ART (antiretroviral therapy) care, ART initiation, and adherence over the long term.

This study aims to determine the effects of Point-of-Care (POC) CD4 testing, POC viral load (VL) testing and several linkage strategies (lay-counselor follow-up, accompaniment to HIV clinic by lay counselor, or clinical referral) on linkage to care and treatment adherence for HIV positive persons.

This study also aims to determine the uptake of voluntary circumcision among HIV uninfected males with either promotion at point of HIV testing, Short Message Service (SMS) follow-up or lay counselor follow-up visits.

Study Type

Interventional

Enrollment (Actual)

2075

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • KwaZulu Natal
      • Sweetwaters, KwaZulu Natal, South Africa
        • Human Sciences Research Council (HSRC)
    • Bushenyi
      • Kabwohe, Bushenyi, Uganda
        • Intergrated Community Based Initivatives (ICOBI)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Reside in the study community
  • Must be 16 years or older
  • Able and willing to provide informed consent/assent for study procedures
  • HIV negative uncircumcised men must be age 16 - 49 years and have access to secure text messaging to be randomized to strategies for male circumcision.

Exclusion Criteria:

  • N/A

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: POC CD4 & Clinic Accompaniment
HIV positive persons not on ART at enrollment, randomized to POC CD4 testing and follow up with clinic accompaniment
Point of Care CD4 testing
Accompaniment to the clinic by a counselor
Active Comparator: POC CD4 & Lay Counselor
HIV positive persons not on ART at enrollment, randomized to POC CD4 testing and lay counselor follow up
Point of Care CD4 testing
Follow-up from a lay counselor
Active Comparator: POC CD4 & Clinic Referral
HIV positive persons not on ART at enrollment, randomized to POC CD4 testing and referral to clinic
Point of Care CD4 testing
Referral to clinic
Active Comparator: CD4 Referral & Clinic Accompaniment
HIV positive persons not on ART at enrollment, randomized to referral for CD4 testing and follow up with clinic accompaniment
Accompaniment to the clinic by a counselor
Referral to CD4 testing
Active Comparator: CD4 Referral & Lay Counselor
HIV positive persons not on ART at enrollment, randomized to referral for CD4 testing and lay counselor follow up
Follow-up from a lay counselor
Referral to CD4 testing
Active Comparator: CD4 Referral & Clinic Referral
HIV positive persons not on ART at enrollment, randomized to referral for CD4 testing and referral to clinic
Referral to clinic
Referral to CD4 testing
Active Comparator: Circumcision - SMS Reminder
HIV negative uncircumcised males, randomized to SMS reminder for male circumcision
SMS reminder for male circumcision
Active Comparator: Circumcision - Lay Counselor
HIV negative uncircumcised males, randomized to lay counselor follow-up for male circumcision
Follow-up from a lay counselor
Active Comparator: Circumcision - Promotion
HIV negative uncircumcised males, randomized to promotion of male circumcision at the time of HIV testing
Promotion of male circumcision at the time of HIV testing
Active Comparator: POC VL
HIV positive persons on ART, randomized to POC viral load testing
POC VL testing for HIV infected persons on ART
Active Comparator: Laboratory based VL assay
HIV positive persons on ART, randomized to laboratory based viral load testing
Laboratory based viral load testing for HIV infected persons on ART

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Linkage to care for HIV infected persons not on treatment following a point-of care CD4 count compared to referral to clinic for CD4 testing
Time Frame: Up to 12 Months
Proportion of HIV positive individuals in the POC CD4 arm who visit a clinic, obtain a staging CD4 test, initiate ART if eligible, or have a viral load <50 copies/mL within 9 months compared to those in the clinic referral arm.
Up to 12 Months
Uptake of male circumcision referral among HIV-uninfected men with either promotion at point of HIV testing, SMS follow-up or lay-counselor follow-up visits
Time Frame: Up to 9 months
Proportion of HIV-uninfected men who visit a male circumcision clinic or outreach venue for information about circumcision and proportion who report being circumcised by month 3 and 9 in the lay-counselor arm compared to the SMS follow-up arm, and male circumcision promotion at HIV testing arm
Up to 9 months
Linkage to care for HIV infected persons after lay counselor follow-up, accompaniment to HIV clinic by lay counselor, or clinic referral
Time Frame: Up to 12 months
Proportion of HIV positive individuals not on ART at baseline who visit a clinic, obtain a staging CD4 test, initiate ART if eligible, or have a viral load <50 copies/mL within 9 months in the lay counselor follow-up arm compared to the accompaniment and clinic referral arms
Up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
POC viral load testing impact on ART adherence and viral suppression compared to standard laboratory testing
Time Frame: Up to 12 months
Proportion of HIV positive persons with viral load <50 copies/mL at 3 months among those who receive POC viral load testing compared to those participants who receive standard laboratory-based viral load testing.
Up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

February 1, 2015

Study Completion (Actual)

February 1, 2015

Study Registration Dates

First Submitted

December 18, 2013

First Submitted That Met QC Criteria

January 14, 2014

First Posted (Estimate)

January 16, 2014

Study Record Updates

Last Update Posted (Estimate)

June 2, 2015

Last Update Submitted That Met QC Criteria

May 29, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV

Clinical Trials on POC CD4 Testing

3
Subscribe